Publicaciones

"Interferón alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls ".

Yurdana Castelruiz, Esther Larrea, Patricia Boya, María-Pilar Civeira and Jesús Prieto.

Hepatology. 1999; 29: 1900-1904.

"Expression of interferon alfa subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferón alfa 5".

E. Larrea, A. Alberdi, Y. Castelruiz, P. Boya, M.-P. Civeira and Jesús Prieto.

Journal of Viral Hepatitis. 2001; 8, 103-110.

“Different antiviral activities of IFN alfa subtypes in human liver cell lines: synergism between IFN alfa 2 and IFN alfa 8 ".

Shigeto Yamamoto, Hirohisa Yano, Osamu Sanou, Hakuo Ikegami, Masashi Kurimoto, Masamichi Kojiro.

Hepatology Research 24. 2002, 99-106.

"IFN alfa 5 mediates stronger Tyk2-Stat-Dependent activation and higher expression of 2', 5' -Oligoadenylate synthetase than IFN alfa 2 in liver cells ".

Esther Larrea, Rafael Aldabe, Jose-Ignacio Riezu-Boj, Anunciata Guitart, Maria Pilar Civeira, Jesús Prieto and Elena Baixeras.

Journal of Interferón & Cytokine Research. 2004, 24:497-503.

"Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies ".

E. Larrea, R. Aldabe, E. Molano, C M. Fernández-Rodriguez, A. Ametzazurra, M P. Civeira and J. Prieto.

Gut. 2006, 000:1-9; doi: 10.1136/gut.2005.070060.